[3] Hwang JE， Kim SH， Jin J， et al. Combination of percutaneous radiofrequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastases from gastric cancer[J]. ClinExp Metastasis， 2014， 31 (1)： 25-32.
[4] Komeda K， Hayashi M， Kubo S， et al. High survival in patients operated for small isolated liver metastases from gastric cancer： a multi institutional study[J]. World J Surg， 2014， 38(10)： 2692-2697.
[5] Yoshida M， Ohtsu A， Boku N， et al. Long-term survival and prognostic factors in patients with metastatic gastric cancers treated with chemotherapy in the Japan Clinical Oncology Group (JCOG) study[J]. Jpn J ClinOncol， 2004， 34 (11)：654-659.
[6] Li D， Kang J， Madoff DC. Locally ablative therapies for primary and metastatic liver cancer[J]. Expert Rev Anticancer Ther， 2014， 14(8)：931-945.
[7] ShanhMA，KelsenDP.Gastriccancer：A primer on the epidemiology and biology of the disease and overview of the medical management of advanced disease.JNatlComprCancNetw，2010，8(4)：437-447.
[8] ShinA，KimJ，ParkS.Gastric cancer epidemiology in Korea.J Gastric Cancer，2011，11(3)：133-140.
[9] SaiuraA，UmekitaN，InoueS， et al.Clinic pathological features and outcome of hepatic resection for liver metastasis from gastric cancer.Hepato-gasroenterology，2002，49(46)：1062-2065.
[10] KeiichiO，TakashiM，KenI，etal.Hepaticresectionformetastatictumorsfromgastriccancer[J].Ann Surg，2002，235 (1)：86-91.
[11] HwangJE，KimSH，JinJ，etal.Combination of percutaneous radio frequency ablation and systemic chemotherapy are effective treatment modalities for metachronous liver metastasis from gastric cancer.CliniExp Metastasis，2014，31(1)：25-32.
[12] GunerA，SonT，ChoI，etal.Liver-directedtreatments for liver metastasis from gastric adenocarcinoma：Comparison between liver resection and radio frequency ablation.Gastric cancer，2016，19(3)：951-960., 百拇医药(李妍 李焕梅 杜俊良 赵月妹 刘淑真 于国华)